Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-08-05
DOI
10.3389/fnagi.2014.00197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
- (2014) Angelique Camilleri et al. CNS Neuroscience & Therapeutics
- α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?
- (2013) Aoife P. Kiely et al. ACTA NEUROPATHOLOGICA
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
- (2013) Silke Appel-Cresswell et al. MOVEMENT DISORDERS
- Mitochondrial Biology and Parkinson's Disease
- (2013) C. Perier et al. Cold Spring Harbor Perspectives in Medicine
- -Synuclein in Parkinson's Disease
- (2013) L. Stefanis Cold Spring Harbor Perspectives in Medicine
- Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls
- (2012) Azadeh Ebrahimi et al. AGEING RESEARCH REVIEWS
- The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
- (2012) I. W. Hamley CHEMICAL REVIEWS
- Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment
- (2012) Jason R. Cannon et al. EXPERIMENTAL NEUROLOGY
- α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, andEscherichia coliExists Predominantly as Disordered Monomer
- (2012) Bruno Fauvet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Accumulation of Toxic -Synuclein Oligomer within Endoplasmic Reticulum Occurs in -Synucleinopathy In Vivo
- (2012) E. Colla et al. JOURNAL OF NEUROSCIENCE
- Protective Effects of the Key Compounds Isolated from Corni fructus against β-Amyloid-Induced Neurotoxicity in PC12 Cells
- (2012) Seung-Young Hong et al. MOLECULES
- Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging
- (2012) Assimina Argyriou et al. NEUROSCIENCE LETTERS
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity
- (2012) Hsieh-Hsun Ho et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Insights into Mitochondrial Dysfunction: Aging, Amyloid-β, and Tau–A Deleterious Trio
- (2011) Karen Schmitt et al. ANTIOXIDANTS & REDOX SIGNALING
- Dihydroxybenzoic Acid Isomers Differentially Dissociate Soluble Biotinyl-Aβ(1–42) Oligomers
- (2011) Harry LeVine et al. BIOCHEMISTRY
- α-Synuclein misfolding and Parkinson's disease
- (2011) Leonid Breydo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Gallic acid provokes DNA damage and suppresses DNA repair gene expression in human prostate cancer PC-3 cells
- (2011) Kuo-Ching Liu et al. ENVIRONMENTAL TOXICOLOGY
- Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
- (2011) Mario Caruana et al. FEBS LETTERS
- Pathological roles of α-synuclein in neurological disorders
- (2011) Kostas Vekrellis et al. LANCET NEUROLOGY
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
- (2011) Laura A. Volpicelli-Daley et al. NEURON
- Cognitive dysfunctions induced by a cholinergic blockade and Aβ25–35 peptide are attenuated by salvianolic acid B
- (2011) Dong Hyun Kim et al. NEUROPHARMACOLOGY
- Entacapone and Tolcapone, Two CatecholO-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
- (2010) Saviana Di Giovanni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting insulin amyloid assembly by small aromatic molecules: Toward rational design of aggregation inhibitors
- (2010) Michal Levy-Sakin et al. Islets
- Neuroprotective Properties of Gallic Acid from Sanguisorbae Radix on Amyloid β Protein (25—35)-Induced Toxicity in Cultured Rat Cortical Neurons
- (2008) Ju Yeon Ban et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- α-Synuclein Misfolding and Neurodegenerative Diseases
- (2008) Vladimir Uversky CURRENT PROTEIN & PEPTIDE SCIENCE
- Unknown
- (2008) G Irvine et al. MOLECULAR MEDICINE
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now